Bioequivalence and Bioavailability Forum

Dear Nirali,

I myself have no sure experience since seldom worked for an FDA submission and always stuck with SAS. Additional said sure is a term which should be avoided in the context of regulatory acceptance . Have a look at ElMaestros signature.

But have a look at this blog "Analyzing clinical trial data with R" or this blog and the documents linked there to get some valuable informations about that topic from an R-viewpoint.

See also "Using R: Perspectives of a FDA Statistical RevieweR" to get the key message "The Food and Drug Administration does not endorse or require use of any specific software".

Hope this helps.